What We're Reading: Page 223
Industry reads hand-picked by our editors
Feb 22, 2019
-
The New York Times
China Uses DNA to Track Its People, With the Help of American Expertise
-
JAMA Viewpoint
The Future of Registries in the Era of Real-world Evidence for Medical Devices
-
Medtech Insight
Spinal Implants: Finding A Manageable Regulatory Pathway Through Complex EU MDR Wording
-
STAT
Intensely private, deeply invested: Richard Sackler’s role in promoting OxyContin emerges in court documents
-
Drug & Device Law
Man Bites Dog – Plaintiff Argues that Device Manufacturer Liable for NOT Having a Representative in the Operating Room – Loses Anyway
Feb 21, 2019
-
The Wall Street Journal
Is It Time for a Better Hospital ID Bracelet?
-
MobiHealthNews
Samsung adds health-focused smartwatch, fitness tracker to its Galaxy lineup
-
Markets Insider
Johnson & Johnson was subpoenaed by the DOJ and the SEC over baby powder safety
-
Retail Dive
L'Oréal taps AI for skin diagnostics
Feb 20, 2019
-
NBC News
'Young blood' company Ambrosia halts patient treatments after FDA warning
-
The Washington Post
With fitness trackers in the workplace, bosses can monitor your every step — and possibly more
-
MobiHealthNews
Novo Nordisk's soon-to-be-released insulin pens will connect to Glooko's diasend platform
-
MIT Technology Review
What if you could diagnose endometriosis with a tampon?
-
RAPS
FDA Warns Ocular Therapeutix Over Failure to Comply With Postapproval Requirements
Feb 19, 2019
-
Drug Delivery Business News
Medtronic: Patient deaths left out of paclitaxel-coated balloon analysis
-
Vox
The latest Instagram influencer frontier? Medical promotions.
-
RAPS
Industry, Advocacy Groups Seek Clarity on Proposed Changes to Informed Consent Rules
-
The New York Times
Dialysis Is a Way of Life for Many Older Patients. Maybe It Shouldn’t Be.
Feb 15, 2019
-
The Washington Post
Breast surgeons say all breast cancer patients should be offered genetic testing
-
Healthcare Dive
UPMC case highlights increased scrutiny of nonprofit hospitals
-
Business Insider
23andMe wants to be a drug company
-
The New York Times
The Instant, Custom, Connected Future of Medical Devices
Feb 14, 2019
-
Axios
A slice of the healthcare sector is disappointing Wall Street
-
STAT News
He went hunting for gold-standard research on artificial intelligence in medicine — and didn’t find much
-
The Washington Post
Behind the failure of the first U.S. uterine transplant
-
Vantage
J&J’s Auris buy looks like a Verb swerve
Previous
